SEC Form 4 · accession 0000911916-16-000556
CoLucid Pharmaceuticals, Inc. · CLCD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Luc Marengere
Director · 10% Owner
Period of report
May 10, 2016
Accepted (ET)
May 12, 2016 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348649
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.24 | May 10, 2016 | A | 8,897 | A | — | May 10, 2026 | Common Stock | 8,897 | 8,897 | D |
Explanation of responses
- F1Options fully vest immediately prior to the start of the Issuer's first annual meeting of stockholders following the date of grant.